Aristada is a long-acting injectable medication used to treat schizophrenia. The 1064 mg dosage is a specific formulation of Aristada.
What is Aristada 1064 mg used for?
The 1064 mg dosage of Aristada is a once-monthly injection indicated for the maintenance treatment of schizophrenia in adults [1]. It contains aripiprazole lauroxil, which is converted to aripiprazole in the body [2].
How does Aristada 1064 mg work?
Aristada 1064 mg works by delivering aripiprazole, an atypical antipsychotic, over a prolonged period. Aripiprazole is thought to work by affecting dopamine and serotonin activity in the brain [2].
What other dosages of Aristada are available?
Aristada is also available in other dosages, including 441 mg, 662 mg, and 882 mg, which are administered every four weeks. Additionally, Aristada Now is available in 662 mg and 882 mg for intramuscular use, administered immediately and followed by a dose of Aristada every four weeks [1].
When does the patent for Aristada expire?
Patent information for Aristada can be complex and may involve multiple patents related to the drug substance, formulation, and method of use. For detailed and up-to-date patent expiry information, it is advisable to consult resources like DrugPatentWatch.com [3].
Who manufactures Aristada?
Aristada is manufactured by Alkermes [1].
What are the potential side effects of Aristada?
Common side effects of Aristada may include injection site reactions, insomnia, headache, and weight gain [2]. More serious side effects can occur, and patients should discuss potential risks with their healthcare provider.
How is Aristada administered?
Aristada 1064 mg is administered as an intramuscular injection by a healthcare professional [1].
How does Aristada compare to other schizophrenia treatments?
As a long-acting injectable, Aristada offers an alternative to daily oral medications, which may improve adherence for some patients. Its efficacy and side effect profile are comparable to other atypical antipsychotics, but its long-acting nature can be a key differentiating factor [2].
---
Sources
[1] Aristada.com
[2] U.S. Food and Drug Administration (FDA) prescribing information for Aristada
[3] DrugPatentWatch.com